{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:42:33Z","timestamp":1793839353314,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008017","name":"Institut Gustave-Roussy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012094","name":"F\u00e9d\u00e9ration Enfants Cancers Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12072-021-10251-1","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T08:02:46Z","timestamp":1631260966000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5093-5742","authenticated-orcid":false,"given":"M.","family":"Illiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Colinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Taque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Larue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Laithier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"V\u00e9rit\u00e9-Goulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sudour-Bonnange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Faure-Conter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Coze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Dumesnil","family":"De Maricourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Branchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brugi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fresneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"issue":"17","key":"10251_CR1","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361(17):1662\u201370.","journal-title":"N Engl J Med"},{"issue":"9","key":"10251_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol ao\u00fbt. 2013;14(9):834\u201342.","journal-title":"Lancet Oncol ao\u00fbt"},{"issue":"22","key":"10251_CR3","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","volume":"18","author":"J Pritchard","year":"2000","unstructured":"Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach\u2014Results of the First Prospective Study of the International Society of Pediatric Oncology. J Clin Oncol. 2000;18(22):3819\u201328.","journal-title":"J Clin Oncol"},{"key":"10251_CR4","first-page":"S36","volume":"18","author":"PR Brock","year":"1992","unstructured":"Brock PR, Yeomans EC, Bellman SC, Pritchard J. Cisplatin therapy in infants: short and long-term morbidity. Br J Cancer Suppl ao\u00fbt. 1992;18:S36-40.","journal-title":"Br J Cancer Suppl ao\u00fbt"},{"issue":"3","key":"10251_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/cphy.c180017","volume":"9","author":"TR Mancilla","year":"2019","unstructured":"Mancilla TR, Iskra B, Aune GJ. Doxorubicin-induced cardiomyopathy in children. Compr Physiol. 2019;9(3):905\u201331.","journal-title":"Compr Physiol"},{"issue":"5","key":"10251_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/08880018.2011.553879","volume":"28","author":"A Varan","year":"2011","unstructured":"Varan A, Kebudi R. Secondary malignant neoplasms after childhood cancer. Pediatr Hematol Oncol ao\u00fbt. 2011;28(5):345\u201353.","journal-title":"Pediatr Hematol Oncol ao\u00fbt"},{"key":"10251_CR7","unstructured":"Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, version 5.0. Available online: http:\/\/www.survivorshipguidelines.org."},{"issue":"9","key":"10251_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"3","key":"10251_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol JASN mars. 2009;20(3):629\u201337.","journal-title":"J Am Soc Nephrol JASN mars"},{"issue":"4","key":"10251_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mpo.2950190415","volume":"19","author":"PR Brock","year":"1991","unstructured":"Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol. 1991;19(4):295\u2013300.","journal-title":"Med Pediatr Oncol"},{"key":"10251_CR11","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute."},{"issue":"282","key":"10251_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457\u2013481.","journal-title":"J Am Stat Assoc."},{"issue":"8","key":"10251_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","volume":"31","author":"KJ Rothman","year":"1978","unstructured":"Rothman KJ. Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis. 1978;31(8):557\u2013660.","journal-title":"J Chronic Dis."},{"key":"10251_CR14","first-page":"2","volume":"8","author":"M Semeraro","year":"2013","unstructured":"Semeraro M, Branchereau S, Maibach R, Zsiros J, Casanova M, Brock P, et al. Relapses in hepatoblastoma patients: Clinical characteristics and outcome \u2013 Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer. 2013;8:2.","journal-title":"Eur J Cancer"},{"issue":"1","key":"10251_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12885-021-08095-x","volume":"21","author":"T Zhi","year":"2021","unstructured":"Zhi T, Zhang W-L, Zhang Y, Hu H-M, Wang Y-Z, Huang D-S. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center. BMC Cancer. 2021;21(1):397.","journal-title":"BMC Cancer"},{"issue":"2","key":"10251_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.surg.2020.12.035","volume":"170","author":"IA Ziogas","year":"2021","unstructured":"Ziogas IA, Benedetti DJ, Wu WK, Matsuoka LK, Izzy M, Rauf MA, et al. Management of hepatoblastoma in the United States: can we do better? Surgery. 2021;170(2):579\u201386.","journal-title":"Surgery"},{"key":"10251_CR17","first-page":"2","volume":"2","author":"PH Kim","year":"2021","unstructured":"Kim PH, Shin HJ, Yoon HM, Choi YH, Namgoong J-M, Kim DY, et al. Children\u2019s hepatic tumors international collaboration-hepatoblastoma stratification (CHIC-HS) system for pediatric patients with hepatoblastoma: a retrospective, hospital-based cohort study in South Korea. Cancer Res Treat. 2021;2:2.","journal-title":"Cancer Res Treat"},{"issue":"3","key":"10251_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R, Aronson D, Brugi\u00e8res L, Brock P, et al. Risk-adapted treatment for childhood hepatoblastoma final report of the second study of the International Society of Paediatric Oncology\u2013SIOPEL 2. Eur J Cancer Oxf Engl. 2004;40(3):411\u201321.","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"25","key":"10251_CR19","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","volume":"378","author":"PR Brock","year":"2018","unstructured":"Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med. 2018;378(25):2376\u201385.","journal-title":"N Engl J Med"},{"issue":"12","key":"10251_CR20","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/cncr.30591","volume":"123","author":"HM Katzenstein","year":"2017","unstructured":"Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, et al. Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: a report from the Children\u2019s Oncology Group AHEP0731 study committee. Cancer. 2017;123(12):2360\u20137.","journal-title":"Cancer"},{"issue":"5","key":"10251_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","volume":"20","author":"HM Katzenstein","year":"2019","unstructured":"Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, et al. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children\u2019s Oncology Group, multicentre, phase 3 trial. Lancet Oncol mai. 2019;20(5):719\u201327.","journal-title":"Lancet Oncol mai"},{"issue":"22","key":"10251_CR22","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1200\/JCO.19.01067","volume":"38","author":"E Hiyama","year":"2020","unstructured":"Hiyama E, Hishiki T, Watanabe K, Ida K, Ueda Y, Kurihara S, et al. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(22):2488\u201398.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"2","key":"10251_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/pbc.26212","volume":"64","author":"A Weiss","year":"2017","unstructured":"Weiss A, Sommer G, Kasteler R, Scheinemann K, Grotzer M, Kompis M, et al. Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study. Pediatr Blood Cancer f\u00e9vr. 2017;64(2):364\u201373.","journal-title":"Pediatr Blood Cancer f\u00e9vr"},{"key":"10251_CR24","first-page":"1","volume":"2","author":"S Haghiri","year":"2021","unstructured":"Haghiri S, Fayech C, Mansouri I, Dufour C, Pasqualini C, Bolle S, et al. Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue. Bone Marrow Transplant. 2021;2:1\u201314.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10251_CR25","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","volume":"120","author":"JG Gurney","year":"2007","unstructured":"Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML, et al. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children\u2019s Oncology Group. Pediatrics. 2007;120(5):e1229-1236.","journal-title":"Pediatrics"},{"key":"10251_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejca.2016.05.006","volume":"64","author":"TG Bonnesen","year":"2016","unstructured":"Bonnesen TG, Winther JF, Asdahl PH, de Fine Licht S, Gudmundsdottir T, S\u00e4llfors Holmqvist A, et al. Long-term risk of renal and urinary tract diseases in childhood cancer survivors: a population-based cohort study. Eur J Cancer. 2016;64:52\u201361.","journal-title":"Eur J Cancer."},{"issue":"10","key":"10251_CR27","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1055-9965.EPI-13-0036","volume":"22","author":"RL Mulder","year":"2013","unstructured":"Mulder RL, Knijnenburg SL, Geskus RB, van Dalen EC, van der Pal HJH, Koning CCE, et al. Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study. Cancer Epidemiol Biomark Prev. 2013;22(10):1736\u201346.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"4","key":"10251_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/1097-0142(19900215)65:4<870::AID-CNCR2820650407>3.0.CO;2-D","volume":"65","author":"J Shapira","year":"1990","unstructured":"Shapira J, Gotfried M, Lishner M, Ravid M. Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation. Cancer. 1990;65(4):870\u20133.","journal-title":"Cancer"},{"issue":"5","key":"10251_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00595-009-4143-1","volume":"40","author":"Y Yuan","year":"2010","unstructured":"Yuan Y, Gotoh M. Biliary complications in living liver donors. Surg Today. 2010;40(5):411\u20137.","journal-title":"Surg Today"},{"issue":"14","key":"10251_CR30","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.4254\/wjh.v7.i14.1856","volume":"7","author":"P Simoes","year":"2015","unstructured":"Simoes P, Kesar V, Ahmad J. Spectrum of biliary complications following live donor liver transplantation. World J Hepatol. 2015;7(14):1856\u201365.","journal-title":"World J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T03:19:32Z","timestamp":1644895172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10251"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10251-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"assertion":[{"value":"13 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M. Illiano, M. Colinard, S. Taque, B. Mallon, C. Larue, V. Laithier, C. V\u00e9rit\u00e9\u2011Goulard, H. Sudour\u2011Bonnange, C. Faure\u2011Conter, C. Coze, I. Aerts, C. Dumesnil De Maricourt, C. Paillard, S. Branchereau, L. Brugi\u00e8res, B. Fresneau have no conflict of interest related to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the <i>Comit\u00e9 de Protection des Personnes Ile-de-France VII<\/i> (project CO-15\u2013003) and was conducted in accordance with the principles of Declaration of Helsinki in 1975.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This was not an animal research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research"}},{"value":"This was a retrospective study with clinical and biological data collection, and the Research Ethics Committee of each participating center approved to waive the patient consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors consented the publish work.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This was a retrospective observation study and was not a drug trial. There was no need for clinical trial registration.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registration"}}]}}